Cellular Therapy Increases Survival in Recurring B-cell Lymphoma - News Center
Briefly

"The bottom line is that all the data from 2020 are holding up in 2024. We have about anywhere from a 40 to 50 percent sustained response and possible cure in a group of patients where the results might have been 5 to 10 percent," said Leo I. Gordon, MD.
B-cells are specialized white blood cells called lymphocytes that generate antibodies to fight off pathogens and viruses.
Read at News Center
[
]
[
|
]